Related Experiment Video
Updated: Mar 20, 2026

08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.7K
Ewing sarcoma: a chronicle of molecular pathogenesis
Sang Kyum Kim1, Yong-Koo Park2
1Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.
Human Pathology
|June 2, 2016
Summary
Ewing sarcoma, a bone tumor, arises from specific genetic alterations involving TET/FET and E26 transformation-specific (ETS) gene fusions. This review details the molecular pathogenesis of this mesenchymal malignancy.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Sarcomas are classified by chromosomal alterations, with Ewing sarcoma characterized by simple genetic changes.
- Ewing sarcoma is a small round cell bone tumor and a mesenchymal malignancy.
Purpose of the Study:
- To review the molecular findings in Ewing sarcoma.
- To explain the molecular pathogenesis of Ewing sarcoma.
Main Methods:
- Literature review of molecular findings in Ewing sarcoma.
- Analysis of genetic alterations, specifically gene translocations.
Main Results:
- Ewing sarcoma pathogenesis involves translocations between TET/FET family genes (TLS/FUS, EWSR1, TAF15) and E26 transformation-specific (ETS) family genes.
- These genetic alterations are simple and specific to sarcoma.
Conclusions:
- Understanding the molecular basis of Ewing sarcoma is crucial for its classification and treatment.
- Recent advances in molecular findings provide insights into the pathogenesis of Ewing sarcoma.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
6.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.6K
Rous Sarcoma Virus (RSV) and Cancer
5.9K
5.9K
Metastasis
6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Tumor Progression
7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression
3.5K
3.5K

